LOTUS Edge Valve System

FDA Premarket Approval P180029 S027

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Modifications to acceptance criteria for visual inspection of the multi-lumen extrusion (mle) component of the lotus edge delivery system

DeviceLOTUS Edge Valve System
Generic NameAortic Valve, Prosthesis, Percutaneously Delivered
ApplicantBoston Scientific Corporation
Date Received2020-09-21
Decision Date2020-10-07
PMAP180029
SupplementS027
Product CodeNPT 
Advisory CommitteeCardiovascular
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address Boston Scientific Corporation 300 Boston Scientific Way marlborough, MA 01752-1234

Supplemental Filings

Supplement NumberDateSupplement Type
P180029Original Filing
S027 2020-09-21 30-day Notice
S026 2020-09-14 30-day Notice
S025 2020-08-10 30-day Notice
S024 2020-06-08 30-day Notice
S023 2020-04-13 30-day Notice
S022
S021 2020-03-06 30-day Notice
S020
S019 2019-12-09 30-day Notice
S018
S017 2019-11-12 30-day Notice
S016 2019-10-15 30-day Notice
S015 2019-10-07 30-day Notice
S014 2019-09-30 30-day Notice
S013
S012 2019-09-23 30-day Notice
S011
S010 2019-08-19 30-day Notice
S009 2019-08-12 30-day Notice
S008
S007 2019-06-27 30-day Notice
S006 2019-06-17 30-day Notice
S005
S004 2019-06-03 30-day Notice
S003
S002
S001 2019-05-06 30-day Notice

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.